Actinium pharmaceuticals, inc. (ATNM)
Income statement / TTM
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11
Revenue

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Operating expenses:
Research and development, net of reimbursements

16,549

18,247

17,644

16,964

17,094

15,694

16,494

17,612

17,719

18,277

18,936

18,636

17,828

16,386

13,528

13,218

13,501

15,120

16,433

14,726

12,267

8,597

5,234

3,613

3,109

3,090

3,989

4,081

3,440

0

0

0

-

General and administrative

5,521

5,553

5,701

6,208

6,732

7,022

6,709

7,867

9,190

10,264

10,002

10,011

9,019

8,486

8,886

9,686

11,274

11,604

12,698

11,434

10,175

8,469

6,410

5,090

3,476

5,716

5,607

4,879

4,506

0

0

0

-

Depreciation expense

-

-

-

-

-

-

-

-

-

66

75

80

-

67

64

61

53

57

55

46

37

23

9

0

-

0

0

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

-

Loss on disposition of equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4

-4

-4

0

-

0

0

-

-

Loss on disposition of equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Cost of Goods

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Gross profit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Bank charges (Expenses)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Other costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Professional fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Total operating expenses

22,071

23,801

23,346

23,172

23,827

22,670

23,168

25,458

26,910

28,530

28,936

28,651

26,847

24,940

22,479

22,966

24,829

26,782

29,187

26,207

22,480

17,092

11,656

8,707

6,591

8,810

9,601

8,964

7,947

4,246

0

0

0

Loss from operations

-22,071

-23,801

-23,346

-23,172

-23,827

-22,670

-23,168

-25,458

-26,910

-28,530

-28,936

-28,651

-26,847

-24,940

-22,479

-22,966

-24,829

-26,782

-29,187

-26,207

-22,480

-17,092

-11,656

-8,707

-6,591

-8,810

-9,601

-8,964

-7,947

-4,246

0

0

0

Other income:
Interest income - net

172

185

181

171

173

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

4

-

7

7

0

-

0

0

-

2

149

466

787

1,099

950

0

0

0

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

Gain on extinguishment of liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

-

Gain on change in fair value of derivative liabilities

-

-

-

-

-

-

-

-

304

396

527

673

2,530

779

970

617

3,812

6,880

7,153

15,151

-2,206

-8,048

-8,827

-18,074

-4,179

1,189

705

1,610

685

0

0

0

-

State corporate tax expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Total other income

172

185

181

171

173

173

496

595

309

396

526

671

2,525

774

965

612

3,804

6,871

7,145

15,144

-2,206

-8,048

-8,828

-18,076

-4,181

1,039

238

823

-413

-1,241

0

0

0

Net loss

-21,899

-23,616

-23,165

-23,001

-23,653

-22,497

-22,672

-24,862

-26,601

-28,133

-28,409

-27,980

-24,321

-24,166

-21,514

-22,353

-21,025

-19,910

-22,041

-11,062

-24,687

-25,141

-20,485

-26,784

-10,773

-7,771

-9,362

-8,141

-8,361

-5,487

0

0

0

Deemed dividend for warrant down-round protection provision

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss applicable to common stockholders

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss per common share - basic and diluted

-0.03

-0.04

-0.03

-0.05

-0.05

-0.06

-0.04

-0.07

-0.05

-0.09

-0.12

-0.14

-0.12

-0.14

-0.14

-0.10

-

-

-

-0.09

-

-0.21

-

-0.66

-

-0.06

-

-0.03

-3.66

-3.76

-0.09

-0.07

-0.01

Weighted average common shares outstanding - basic and diluted

165,007

163,338

151,544

117,197

114,905

110,463

110,363

88,434

80,365

72,543

58,184

55,892

55,477

47,651

46,470

44,253

-

-

-

33,256

-

28,496

-

25,228

-

23,601

-

21,391

-27,109

801

17,020

13,701

-

Net loss per common share - basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.10

-0.20

-

-

-

0.14

-

-

-

-0.13

-

-

-

-

-

-

Net loss per common share - diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.10

-0.20

-

-

-

0.10

-

-

-

-0.13

-

-

-

-

-

-

Weighted average common shares outstanding - basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

41,167

36,650

-

-

-

25,795

-

-

-

22,178

-

-

-

-

-

-

Weighted average common shares outstanding - diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

41,167

36,650

-

-

-

35,862

-

-

-

22,178

-

-

-

-

-

-

Weighted average of shares outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,155